AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 190,500 shares, a growth of 46.9% from the May 15th total of 129,700 shares. Based on an average daily volume of 3,800 shares, the short-interest ratio is currently 50.1 days.

AstraZeneca Stock Performance

AstraZeneca stock opened at $148.35 on Tuesday. AstraZeneca has a twelve month low of $120.64 and a twelve month high of $175.00. The stock’s 50 day moving average is $139.59 and its 200 day moving average is $140.35.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.